Diabetic Ketoacidosis Management - PowerPoint PPT Presentation

About This Presentation
Title:

Diabetic Ketoacidosis Management

Description:

Diabetic Ketoacidosis Management Heidi Chamberlain Shea, MD Endocrine Associates of Dallas Goals of Discussion Pathophysiology of DKA Biochemical criteria for DKA ... – PowerPoint PPT presentation

Number of Views:644
Avg rating:3.0/5.0
Slides: 34
Provided by: heidi60
Category:

less

Transcript and Presenter's Notes

Title: Diabetic Ketoacidosis Management


1
Diabetic Ketoacidosis Management
  • Heidi Chamberlain Shea, MD
  • Endocrine Associates of Dallas

2
Goals of Discussion
  • Pathophysiology of DKA
  • Biochemical criteria for DKA
  • Treatment of DKA
  • Prevention of DKA
  • Hyperosmolar Nonketoic Syndrome

3
Epidemiology
  • Annual incidence in U.S.
  • 5-8 per 1000 diabetic subjects
  • 2.8 of all diabetic admissions are due to DKA
  • Overall mortality rate ranges from 2-10
  • Higher is older patients

4
DKAPrecipitating Factors
  • Failure to take insulin
  • Failure to increase insulin
  • Illness/Infection
  • Pneumonia
  • MI
  • Stroke
  • Acute stress
  • Trauma
  • Emotional
  • Medical Stress
  • Counterregulatory hormones
  • Oppose insulin
  • Stimulate glucagon release
  • Hypovolmemia
  • Increases glucagon and catecholamines
  • Decreased renal blood flow
  • Decreases glucagon degradation by the kidney

5
Diabetic Ketoacidosis
  • Due to
  • Severe insulin deficiency
  • Excess counterregulatory hormones
  • Glucagon
  • Epinephrine
  • Cortisol
  • Growth hormone

6
Role of Insulin
  • Required for transport of glucose into
  • Muscle
  • Adipose
  • Liver
  • Inhibits lipolysis
  • Absence of insulin
  • Glucose accumulates in the blood
  • Liver
  • Uses amino acids for gluconeogenesis
  • Converts fatty acids into ketone bodies
  • Acetone, Acetoacetate, ß-hydroxybutyrate
  • Increased counterregulatory hormones

7
Counterregulatory Hormones - DKA
Increases insulin resistance Activates glycogenolysis and gluconeogenesis Activates lipolysis Inhibits insulin secretion
Epinephrine X X X X
Glucagon X
Cortisol X X
Growth Hormone X X X
8
Insulin Deficiency
Glucose uptake
Lipolysis
Proteolysis
Free Fatty Acids
Glycerol
Amino Acids
Gluconeogenesis Glycogenolysis
Hyperglycemia
Ketogenesis
Acidosis
Osmotic diuresis
Dehydration
9
Signs and Symptoms of DKA
  • Polyuria, polydipsia
  • Enuresis
  • Dehydration
  • Tachycardia
  • Orthostasis
  • Abdominal pain
  • Nausea
  • Vomiting
  • Fruity breath
  • Acetone
  • Kussmaul breathing
  • Mental status changes
  • Combative
  • Drunk
  • Coma

10
Lab Findings
  • Hyperglycemia
  • Anion gap acidosis
  • (Na K) (Cl Bicarb) gt12
  • Bicarbonate lt15 mEq/L
  • pH lt7.3
  • Urine ketones and serum ketones
  • Hyperosmolarity

11
Differential Diagnosis Anion Gap Acidosis
  • Alcoholic ketoacidosis
  • Lactic acidosis
  • Renal failure
  • Ethylene glycol or methyl alcohol poisoning
  • Starvation in late pregnancy or lactation (rare)

12
Atypical Presentations
  • DKA can be present with BS lt300
  • Impaired gluconeogenesis
  • Liver disease
  • Acute alcohol ingestion
  • Prolonged fasting
  • Insulin-independent glucose is high (pregnancy)
  • Chronic poor control but taking insulin
  • Bedside urine ketones false negatives
  • Measure acetoacetate not ß-hydroxybutyrate
  • Send blood to lab

13
Treatment of DKA
  • Initial hospital management
  • Replace fluid and electrolytes
  • IV Insulin therapy
  • Glucose administration
  • Watch for complications
  • Disconnect insulin pump
  • Once resolved
  • Convert to home insulin regimen
  • Prevent recurrence

14
Treatment of DKAFluids and Electrolytes
  • Fluid replacement
  • Restores perfusion of the tissues
  • Lowers counterregulatory hormones
  • Average fluid deficit 3-5 liters
  • Initial resuscitation
  • 1-2 liters of normal saline over the first 2
    hours
  • Slower rates of 500cc/hr x 4 hrs or 250 cc/hr x 4
    hours
  • When fluid overload is a concern
  • If hypernatremia develops ½ NS can be used

15
Treatment of DKAFluids and Electrolytes
  • Hyperkalemia initially present
  • Resolves quickly with insulin drip
  • Once urine output is present and Klt5.0, add 20-40
    meq KCL per liter.
  • Normo/Hypokalemia
  • Malnourished individuals (alcoholics)
  • Start K replacement and have K gt 3.0 prior to
    start of insulin
  • Remember to check Magnesium
  • Phosphate deficit
  • May want to use Kphos
  • Bicarbonate not given unless pH lt7 or bicarbonate
    lt5 mmol/L

16
Treatment of DKAInsulin Therapy
  • IV bolus of 0.1-0.2 units/kg ( 10 units) regular
    insulin
  • Follow with hourly regular insulin infusion
  • Glucose levels
  • Decrease 75-100 mg/dl hour
  • Minimize rapid fluid shifts
  • Continue IV insulin until urine is free of ketones

17
Treatment of DKAGlucose Administration
  • Supplemental glucose
  • Hypoglycemia occurs
  • Insulin has restored glucose uptake
  • Suppressed glucagon
  • Prevents rapid decline in plasma osmolality
  • Rapid decrease in insulin could lead to cerebral
    edema
  • Glucose decreases before ketone levels decrease
  • Start glucose when plasma glucose lt300 mg/dl

18
Insulin-Glucose Infusion for DKA
Blood glucose Insulin Infusion D5W Infusion
lt70 0.5 units/hr 150 cc/hr
70-100 1.0 125
101-150 2.0 100
151-200 3.0 100
201-250 4.0 75
251-300 6.0 50
301-350 8.0 0
351-400 10.0 0
401-450 12.0 0
451-500 15.0 0
gt500 20.0 0
19
Complications of DKA
  • Infection
  • Precipitates DKA
  • Fever
  • Leukocytosis can be secondary to acidosis
  • Shock
  • If not improving with fluids r/o MI
  • Vascular thrombosis
  • Severe dehydration
  • Cerebral vessels
  • Occurs hours to days after DKA
  • Pulmonary Edema
  • Result of aggressive fluid resuscitation
  • Cerebral Edema
  • First 24 hours
  • Mental status changes
  • Tx Mannitol
  • May require intubation with hyperventilation

20
Once DKA ResolvedTreatment
  • Most patients require 0.5-0.6 units/kg/day
  • Pubertal or highly insulin resistant patients
  • 0.8-1.0 units/kg/day
  • Long acting insulin
  • 1/2-2/3 daily requirement
  • NPH, Levemir or Lantus
  • Short acting insulin
  • 1/3-1/2 given at meals
  • Regular, Humalog, Novolog or Apidra

21
Once DKA ResolvedTreatment
  • Give SQ insulin at least 2 hours prior to
    stopping insulin infusion.
  • Lantus or Levemir
  • Steady state at 2-4 hrs
  • Short acting analogs for meal times
  • If transitioning to the pump
  • Restart the pump and after 30 minutes stop
    insulin infusion
  • May still be more insulin resistant so will need
    more than usual dose
  • Check blood sugars in 2 hrs
  • Offer supplemental

22
I
23
Insulin Types and Action
24
Prevention of DKASick Day Rules
  • Never omit insulin
  • Cut long acting in half
  • Prevent dehydration and hypoglycemia
  • Monitor blood sugars frequently
  • Monitor for ketosis
  • Provide supplemental fast acting insulin
  • Treat underlying triggers
  • Maintain contact with medical team

25
Preventing DKA
  • Education
  • Sick days
  • Do not stop insulin but adjust
  • Hyperglycemia
  • If gt 300 mg/dl, then check urine ketones
  • If ketones positive
  • Increase fluids
  • Take supplemental insulin Q2 hrs
  • Insulin temperature sensitive
  • lt 77 degrees
  • Teenagers, homeless, pen and pump users
  • Do not store insulin in the car
  • Traveling and summer outdoor activities
  • May need to replace more frequently

26
Goals of Discussion
  • Pathophysiology of DKA
  • Biochemical criteria for DKA
  • Treatment of DKA
  • Prevention of DKA
  • Hyperosmolar Nonketoic Syndrome

27
Hyperosmolar Nonketotic Syndrome
  • Extreme hyperglycemia and dehydration
  • Unable to excrete glucose as quickly as it enters
    the extracellular space
  • Maximum hepatic glucose output results in a
    plateau of plasma glucose no higher than 300-500
    mg/dl
  • When sum of glucose excretion plus metabolism is
    less than the rate which glucose enters
    extracellular space.

28
Hyperosmolar Nonketotic Syndrome
  • Extreme hyperglycemia and hyperosmolarity
  • High mortality (12-46)
  • At risk
  • Older patients with intercurrent illness
  • Impaired ability to ingest fluids
  • Urine volume falls
  • Decreased glucose excretion
  • Elevated glucose causes CNS dysfunction and fluid
    intake impaired
  • No ketones
  • Some insulin may be present
  • Extreme hyperglycemia inhibits lipolysis

29
Hyperosmolar Nonketotic Syndrome Presentation
  • Extreme dehydration
  • Supine or orthostatic hypotension
  • Confusion coma
  • Neurological findings
  • Seizures
  • Transient hemiparesis
  • Hyperreflexia
  • Generalized areflexia

30
Hyperosmolar Nonketotic Syndrome Presentation
  • Glucose gt600 mg/dl
  • Sodium
  • Normal, elevated or low
  • Potassium
  • Normal or elevated
  • Bicarbonate gt15 mEq/L
  • Osmolality gt320 mOsm/L

31
Hyperosmolar Nonketotic Syndrome Treatment
  • Fluid repletion
  • NS 2-3 liters rapidly
  • Total deficit 10 liters
  • Replete ½ in first 6 hours
  • Insulin
  • Make sure perfusion is adequate
  • Insulin drip 0.1U/kg/hr
  • Treat underlying precipitating illness

32
Clinical Errors
  • Fluid shift and shock
  • Giving insulin without sufficient fluids
  • Using hypertonic glucose solutions
  • Hyperkalemia
  • Premature potassium administration before insulin
    has begun to act
  • Hypokalemia
  • Failure to administer potassium once levels
    falling
  • Recurrent ketoacidosis
  • Premature discontinuation of insulin and fluids
    when ketones still present
  • Hypoglycemia
  • Insufficient glucose administration

33
Conclusion
  • Successful management requires
  • Judicious use of fluids
  • Establish good perfusion
  • Insulin drip
  • Steady decline
  • Complete resolution of ketosis
  • Electrolyte replacement
  • Frequent neurological evaluations
  • High suspicion for complications
  • Determine etiology to avoid recurrent episodes
Write a Comment
User Comments (0)
About PowerShow.com